141 related articles for article (PubMed ID: 9394771)
1. Can therapy even be denied for Helicobacter pylori infection?
Graham DY
Gastroenterology; 1997 Dec; 113(6 Suppl):S113-7. PubMed ID: 9394771
[TBL] [Abstract][Full Text] [Related]
2. Do ulcers burn out or burn on? Managing duodenal ulcer diathesis in the Helicobacter pylori era. Ad Hoc Committee on FDA-Related Matters.
Neil GA
Am J Gastroenterol; 1997 Mar; 92(3):387-93. PubMed ID: 9068456
[TBL] [Abstract][Full Text] [Related]
3. Review article: impact of Helicobacter pylori on society-role for a strategy of 'search and eradicate'.
Forman D; Graham DY
Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():17-21. PubMed ID: 14725574
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection in Japan: current status and future options.
Graham DY; Kimura K; Shimoyama T; Takemoto T
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S1-4. PubMed ID: 7735923
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
[TBL] [Abstract][Full Text] [Related]
6. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma.
Graham DY
Prev Med; 1994 Sep; 23(5):712-6. PubMed ID: 7845945
[TBL] [Abstract][Full Text] [Related]
7. [Helicobacter pylori in peptic ulcer and gastric cancer].
Matsukura N; Onda M; Yamashita K
Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
[TBL] [Abstract][Full Text] [Related]
8. [Helicobacter pylori--friend or foe?].
Ciortescu I; Stan M
Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):619-24. PubMed ID: 21243784
[TBL] [Abstract][Full Text] [Related]
9. Appropriate strategies for testing and treating Helicobacter pylori in children: when and how?
Sherman PM
Am J Med; 2004 Sep; 117 Suppl 5A():30S-35S. PubMed ID: 15478850
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori disease in childhood.
Blecker U
Clin Pediatr (Phila); 1996 Apr; 35(4):175-83. PubMed ID: 8665750
[TBL] [Abstract][Full Text] [Related]
11. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer?
Imrie C; Rowland M; Bourke B; Drumm B
Pediatrics; 2001 Feb; 107(2):373-80. PubMed ID: 11158472
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom.
Milne R; Logan RP; Harwood D; Misiewicz JJ; Forman D
Gut; 1995 Sep; 37(3):314-8. PubMed ID: 7590423
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection.
Koizumi W; Tanabe S; Imaizumi H; Hibi K; Kida M; Ohida M; Okayasu I; Saigenji K
Hepatogastroenterology; 2003; 50(49):293-6. PubMed ID: 12630044
[TBL] [Abstract][Full Text] [Related]
14. Current treatment of Helicobacter pylori infection and peptic ulcer disease.
Cleghorn G
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(3):178-82. PubMed ID: 9230534
[TBL] [Abstract][Full Text] [Related]
15. Vaccine against Helicobacter pylori: Inevitable approach.
Talebi Bezmin Abadi A
World J Gastroenterol; 2016 Mar; 22(11):3150-7. PubMed ID: 27003991
[TBL] [Abstract][Full Text] [Related]
16. [Is the only good Helicobacter a dead Helicobacter?].
Katicic M
Med Arh; 2002; 56(1 Suppl 1):17-20. PubMed ID: 12055716
[TBL] [Abstract][Full Text] [Related]
17. Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines.
Lee J; O'Morain C
Gastroenterology; 1997 Dec; 113(6 Suppl):S99-106. PubMed ID: 9394769
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori: ulcers and more: the beginning of an era.
Lacy BE; Rosemore J
J Nutr; 2001 Oct; 131(10):2789S-2793S. PubMed ID: 11584108
[TBL] [Abstract][Full Text] [Related]
19. Prospects for the development of a vaccine against Helicobacter pylori.
Telford JL; Ghiara P
Drugs; 1996 Dec; 52(6):799-804. PubMed ID: 8957151
[TBL] [Abstract][Full Text] [Related]
20. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K
J Gastroenterol; 2007 Jan; 42 Suppl 17():21-7. PubMed ID: 17238021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
